Table 2 Summary of patient demographics... | American Society of Hematology

Table 2

Summary of patient demographics for schedules A and B

Characteristic	Schedule A* (N = 32)	Schedule B† (N = 36)
Age (y)
Mean (SD)	61.2 (9.62)	62.3 (13.25)
Median	61.0	61.0
Minimum, maximum	45, 82	38, 79
Sex
Male	20 (63%)	22 (61%)
Female	12 (38%)	14 (39%)
Ethnicity
Hispanic or Latino	0	1 (3%)
Not Hispanic or Latino	31 (97%)	34 (94%)
Unknown	1 (3%)	1 (3%)
Race
White	27 (84%)	29 (80%)
Black	5 (16%)	6 (17%)
Other	0	1 (3%)

Characteristic	Schedule A* (N = 32)	Schedule B† (N = 36)
Age (y)
Mean (SD)	61.2 (9.62)	62.3 (13.25)
Median	61.0	61.0
Minimum, maximum	45, 82	38, 79
Sex
Male	20 (63%)	22 (61%)
Female	12 (38%)	14 (39%)
Ethnicity
Hispanic or Latino	0	1 (3%)
Not Hispanic or Latino	31 (97%)	34 (94%)
Unknown	1 (3%)	1 (3%)
Race
White	27 (84%)	29 (80%)
Black	5 (16%)	6 (17%)
Other	0	1 (3%)

SD, standard deviation.

Schedule A dosing was once weekly on days 1, 8, and 15 of 4-week cycles.

Schedule B dosing was twice weekly on days 1, 4, 8, and 11 of 3-week cycles; schedule B patients could receive low-dose Dex.